SYNLAB AG
SYNLAB AG provides medical diagnostic services and specialty testing services for hospitals, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. SYNLAB AG was founded in 1998 and is based in Munich, Germany.
SYNLAB AG (SYAB) - Total Liabilities
Latest total liabilities as of March 2024: €2.34 Billion EUR
Based on the latest financial reports, SYNLAB AG (SYAB) has total liabilities worth €2.34 Billion EUR as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SYNLAB AG - Total Liabilities Trend (2020–2023)
This chart illustrates how SYNLAB AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SYNLAB AG Competitors by Total Liabilities
The table below lists competitors of SYNLAB AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Copperbank Resources Corp
OTCQX:CPPKF
|
USA | $3.49 Million |
|
Sam Yung Tradi
KO:002810
|
Korea | ₩105.96 Billion |
|
TWOWAY Communications, Inc.
TW:8045
|
Taiwan | NT$610.47 Million |
|
Datamatics Global Services Limited
NSE:DATAMATICS
|
India | ₹7.08 Billion |
|
Jiangshan Oupai Door Industry Co Ltd
SHG:603208
|
China | CN¥2.02 Billion |
|
Banvida
SN:BANVIDA
|
Chile | CL$115.77 Billion |
|
ASOS Plc
PINK:ASOMF
|
USA | $1.46 Billion |
|
Auswide Bank Ltd
AU:ABA
|
Australia | AU$4.97 Billion |
Liability Composition Analysis (2020–2023)
This chart breaks down SYNLAB AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SYNLAB AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SYNLAB AG (2020–2023)
The table below shows the annual total liabilities of SYNLAB AG from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €2.33 Billion | -23.72% |
| 2022-12-31 | €3.05 Billion | -3.86% |
| 2021-12-31 | €3.17 Billion | -22.29% |
| 2020-12-31 | €4.08 Billion | -- |